Giulia Occhipinti
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications.
Journal: Frontiers in genetics
Published: September 27, 2019
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 19, 2019
CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?
Journal: Journal of oncology
Published: March 27, 2019
Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.
Journal: PloS one
Published: December 13, 2018
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data.
Journal: Frontiers in oncology
Published: June 22, 2018
Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 25, 2017
Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 25, 2016
The choice of endogenous controls in exosomal microRNA assessments from biofluids.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 22, 2016
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.
Journal: Molecular diagnosis & therapy
Published: March 05, 2016
Biocomplexity in Populations of European Anchovy in the Adriatic Sea.
Journal: PloS one
Published: November 18, 2015
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma.
Journal: Oncotarget
Published: July 15, 2015
Last Updated: 09/26/2026